Drugs / FluMist/B/Yamagata
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00952705 Comparator | Aug 2009 → Jan 2010 | — | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluMist/B/Yamagata | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00952705 ↗ |
| Modality | Vaccine | “FluMist/B/Yamagata was administered intranasally using a Becton Dickinson Accuspray™ device” NCT00952705 ↗ |
| Route | Intranasal | “administered intranasally using a Becton Dickinson Accuspray™ device” NCT00952705 ↗ |